Reaching for 90:90:90 in Correctional Facilities in South Africa and Zambia: Virtual Cross-Section of Coverage of HIV Testing and Antiretroviral Therapy During Universal Test and Treat Implementation.

dc.contributor.affiliationInstitute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC.
dc.contributor.affiliationCollege of Public Health Medicine and Veterinary Sciences, James Cook University, Townsville, Australia.
dc.contributor.affiliationDepartment of Medicine, Johns Hopkins University, Baltimore, MD.
dc.contributor.affiliationNossal Institute for Global Health, University of Melbourne, Melbourne, Australia.
dc.contributor.affiliationDepartment of Family Medicine, School of Medicine, University of Pretoria, Pretoria, South Africa; and.
dc.contributor.affiliationDepartment of Medicine, Division of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
dc.contributor.affiliationTB HIV Care, Cape Town, South Africa.
dc.contributor.affiliationThe Aurum Institute, Johannesburg, South Africa.
dc.contributor.affiliationSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
dc.contributor.affiliationDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
dc.contributor.authorHoffmann CJ
dc.contributor.authorHerce ME
dc.contributor.authorChimoyi L
dc.contributor.authorSmith HJ
dc.contributor.authorTlali M
dc.contributor.authorOlivier CJ
dc.contributor.authorTopp SM
dc.contributor.authorMuyoyeta M
dc.contributor.authorReid SE
dc.contributor.authorHausler H
dc.contributor.authorCharalambous S
dc.contributor.authorFielding K
dc.date.accessioned2025-05-23T11:42:46Z
dc.date.issued2024-Aug-15
dc.description.abstractBACKGROUND: People in correctional settings are a key population for HIV epidemic control. We sought to demonstrate scale-up of universal test and treat in correctional facilities in South Africa and Zambia through a virtual cross-sectional analysis. METHODS: We used routine data on 2 dates: At the start of universal test and treat implementation (time 1, T1) and 1 year later (time 2, T2). We obtained correctional facility census lists for the selected dates and matched HIV testing and treatment data to generate virtual cross-sections of HIV care continuum indicators. RESULTS: In the South African site, there were 4193 and 3868 people in the facility at times T1 and T2; 43% and 36% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 1803 (43%) and 1386 (36%) had known HIV status, 804 (19%) and 845 (21%) were known to be living with HIV, and 60% and 56% of those with known HIV were receiving antiretroviral therapy (ART). In the Zambian site, there were 1467 and 1366 people in the facility at times T1 and T2; 58% and 92% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 857 (59%) and 1263 (92%) had known HIV status, 277 (19%) and 647 (47%) were known to be living with HIV, and 68% and 68% of those with known HIV were receiving ART. CONCLUSIONS: This virtual cross-sectional analysis identified gaps in HIV testing coverage, and ART initiation that was not clearly demonstrated by prior cohort-based studies.
dc.identifier.doi10.1097/QAI.0000000000003456
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10724
dc.sourceJournal of acquired immune deficiency syndromes (1999)
dc.titleReaching for 90:90:90 in Correctional Facilities in South Africa and Zambia: Virtual Cross-Section of Coverage of HIV Testing and Antiretroviral Therapy During Universal Test and Treat Implementation.

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
article.pdf
Size:
849.84 KB
Format:
Adobe Portable Document Format

Collections